DK127727B - Fremgangsmåde til fremstilling af et 1,4-diensteroid af androstan- eller pregnanrækken og med usubstitueret 3-stilling. - Google Patents
Fremgangsmåde til fremstilling af et 1,4-diensteroid af androstan- eller pregnanrækken og med usubstitueret 3-stilling.Info
- Publication number
- DK127727B DK127727B DK218567AA DK218567A DK127727B DK 127727 B DK127727 B DK 127727B DK 218567A A DK218567A A DK 218567AA DK 218567 A DK218567 A DK 218567A DK 127727 B DK127727 B DK 127727B
- Authority
- DK
- Denmark
- Prior art keywords
- diensteroid
- androstane
- unsubstituted
- preparation
- pregnane series
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54480066A | 1966-04-25 | 1966-04-25 | |
US62246867A | 1967-03-13 | 1967-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK127727B true DK127727B (da) | 1973-12-24 |
Family
ID=27067737
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK218567AA DK127727B (da) | 1966-04-25 | 1967-04-25 | Fremgangsmåde til fremstilling af et 1,4-diensteroid af androstan- eller pregnanrækken og med usubstitueret 3-stilling. |
DK268871AA DK128208B (da) | 1966-04-25 | 1971-06-02 | Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK268871AA DK128208B (da) | 1966-04-25 | 1971-06-02 | Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling. |
Country Status (12)
Country | Link |
---|---|
US (1) | US3574196A (da) |
JP (1) | JPS495335B1 (da) |
BE (1) | BE697544A (da) |
CH (1) | CH538459A (da) |
DE (1) | DE1618058B1 (da) |
DK (2) | DK127727B (da) |
ES (1) | ES339707A1 (da) |
FR (2) | FR1529732A (da) |
GB (2) | GB1192062A (da) |
IL (1) | IL27840A (da) |
NL (1) | NL6705803A (da) |
SE (2) | SE362073B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5135936U (da) * | 1974-09-06 | 1976-03-17 | ||
JPS5135937U (da) * | 1974-09-06 | 1976-03-17 |
-
1967
- 1967-03-13 US US622468A patent/US3574196A/en not_active Expired - Lifetime
- 1967-04-21 IL IL27840A patent/IL27840A/en unknown
- 1967-04-24 ES ES339707A patent/ES339707A1/es not_active Expired
- 1967-04-24 GB GB63268/69A patent/GB1192062A/en not_active Expired
- 1967-04-24 GB GB08663/67A patent/GB1192061A/en not_active Expired
- 1967-04-24 CH CH578367A patent/CH538459A/de not_active IP Right Cessation
- 1967-04-25 DE DE1967A0055538 patent/DE1618058B1/de not_active Withdrawn
- 1967-04-25 JP JP42026076A patent/JPS495335B1/ja active Pending
- 1967-04-25 SE SE17633/70A patent/SE362073B/xx unknown
- 1967-04-25 NL NL6705803A patent/NL6705803A/xx unknown
- 1967-04-25 FR FR104147A patent/FR1529732A/fr not_active Expired
- 1967-04-25 DK DK218567AA patent/DK127727B/da unknown
- 1967-04-25 BE BE697544D patent/BE697544A/xx unknown
- 1967-04-25 SE SE5833/67A patent/SE342237B/xx unknown
- 1967-07-24 FR FR115422A patent/FR8354M/fr not_active Expired
-
1971
- 1971-06-02 DK DK268871AA patent/DK128208B/da unknown
Also Published As
Publication number | Publication date |
---|---|
IL27840A (en) | 1972-04-27 |
SE342237B (da) | 1972-01-31 |
NL6705803A (da) | 1967-10-26 |
DK128208B (da) | 1974-03-18 |
FR8354M (da) | 1971-02-08 |
BE697544A (da) | 1967-10-02 |
JPS495335B1 (da) | 1974-02-06 |
FR1529732A (fr) | 1968-06-21 |
CH538459A (de) | 1973-06-30 |
SE362073B (da) | 1973-11-26 |
GB1192062A (en) | 1970-05-20 |
DE1793749B2 (de) | 1975-07-24 |
ES339707A1 (es) | 1968-05-16 |
US3574196A (en) | 1971-04-06 |
DE1793749A1 (de) | 1973-05-03 |
GB1192061A (en) | 1970-05-20 |
DE1618058B1 (de) | 1972-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK129701B (da) | Fremgangsmåde til fremstilling af steroider af androstanrækken. | |
FI45857C (fi) | Menetelmä 17-(alkynyylisubstituoitujen) 11beta, 13beta-dialkylgon-4-ee ni-3,17beta-dioli-3-monoestereiden ja 3,17-diestereiden valmistamiseks i. | |
DK124680B (da) | Fremgangsmåde til fremstilling af 2'-substituerede steroid-[16α, 17α-d]-oxazoliner af pregnanrækken. | |
DK127727B (da) | Fremgangsmåde til fremstilling af et 1,4-diensteroid af androstan- eller pregnanrækken og med usubstitueret 3-stilling. | |
IL34976A0 (en) | New 21,21-dichloro steroids of the pregnane series | |
DK120540B (da) | Fremgangsmåde til fremstilling af 17α-alkynyl-17β-acyloxysteroider af androstan- eller estranrækken. | |
DK115989B (da) | Fremgangsmåde til fremstilling af Δ<5(10)>-3-keto-19-nor-steroider af androstan- og pregnanrækken. | |
DK115472B (da) | Fremgangsmåde til fremstilling af 11-hydroxylerede steroider af pregnanrækken. | |
DK114060B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken. | |
DK124539B (da) | Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken. | |
DK122275B (da) | Fremgangsmåde til fremstilling af 17α-ætynyl-17β-hydroksysteroider af androstan- eller østranrækken. | |
DK127420B (da) | Analogifremgangsmåde til fremstilling af 6α-fluor-16α,18-dimethyl-1,4-pregnadien-3,20-dionderivater. | |
FI46158C (fi) | Menetelmä 14beta-hydroksikard-20(22)-enolidi- ja bufa-20,22-dienolidij ohdannaisten valmistamiseksi. | |
DK119657B (da) | Fremgangsmåde til fremstilling af 17α-acyloxy-21-hydroxy-steroider af pregnanrækken. | |
DK132121B (da) | Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion. | |
DK126937B (da) | Fremgangsmåde til fremstilling af 4,6-dihalogen-16-alkyliden-17α-hydroxy-pregna-4,6-dien-3,20-dioner. | |
DK126649B (da) | Analogifremgangsmåde til fremstilling af 18-methylensteroider af pregnan- eller 19-nor-pregnanrækken. | |
DK120487B (da) | Fremgangsmåde til fremstilling af ætynylderivater af oxosteroider af pregnan-, østran- eller androstanrækken. | |
YU33977B (en) | Process for preparing 4,6-dichloro-4,6-steroids of the pregnane and androstane series | |
DK123408B (da) | Fremgangsmåde til fremstilling af et 9α-halogen-11β-substitueret steroid af pregnan- eller androstanrækken. | |
IL32219A0 (en) | 9beta,10alpha-steroids of the pregnane series | |
IL33017A0 (en) | 6,9,21-trihalogenosteroids of the pregnane series | |
DK118461B (da) | Fremgangsmåde til fremstilling af 6-halogen- eller -alkylsubstituerede 4-chlor-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. | |
DK113639B (da) | Analogifremgangsmåde til fremstilling af 9α-flour-11β-hydroxypregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner. | |
DK126252B (da) | Fremgangsmåde til fremstilling af 17-usubstituerede 16-oxygenerede androstanderivater. |